Maryse Lapeyre-Mestre

发表

Identification and tracking of addictovigilance signals in general practice: which interactions between the general practitioners and the French addictovigilance network?

Maryse Lapeyre-Mestre, 2018, Fundamental & clinical pharmacology.

Guillain-Barré Syndrome and Adjuvanted Pandemic Influenza A (H1N1) 2009 Vaccines: A Multinational Self-Controlled Case Series in Europe

Martijn Schuemie, Henrik Svanström, Jan Bonhoeffer, 2014, PloS one.

Drug related falls: a study in the French Pharmacovigilance database

Maryse Lapeyre-Mestre, M. Lapeyre-Mestre, J. Montastruc, 2005, Pharmacoepidemiology and drug safety.

Non-steroidal anti-inflammatory drugs (NSAIDs) and hypertension treatment intensification: a population-based cohort study

Maryse Lapeyre-Mestre, J. Fournier, M. Lapeyre-Mestre, 2012, European Journal of Clinical Pharmacology.

Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance database

Maryse Lapeyre-Mestre, M. Lapeyre-Mestre, J. Montastruc, 2011, BMC clinical pharmacology.

The importance of drug–drug interactions as a cause of adverse drug reactions: a pharmacovigilance study of serotoninergic reuptake inhibitors in France

Eric Bui, Maryse Lapeyre-Mestre, M. Lapeyre-Mestre, 2012, European Journal of Clinical Pharmacology.

Drug interactions with cholinesterase inhibitors: an analysis of the French pharmacovigilance database and a comparison of two national drug formularies (Vidal, British National Formulary).

Maryse Lapeyre-Mestre, M. Lapeyre-Mestre, A. Sommet, 2007, Drug safety.

Comment on: "Social Media Mining for Toxicovigilance: Automatic Monitoring of Prescription Medication Abuse from Twitter"

Michel Mallaret, Joëlle Micallef, Maryse Lapeyre-Mestre, 2017, Drug Safety.

Use of multiple sources and capture–recapture method to estimate the frequency of hospitalizations related to drug abuse

Maryse Lapeyre-Mestre, Laure Pourcel, M. Lapeyre-Mestre, 2012, Pharmacoepidemiology and drug safety.

Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database.

Maryse Lapeyre-Mestre, M. Lapeyre-Mestre, A. Sommet, 2011, British journal of clinical pharmacology.